| __timestamp | Blueprint Medicines Corporation | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 94231000 |
| Thursday, January 1, 2015 | 48588000 | 146394000 |
| Friday, January 1, 2016 | 81131000 | 188272000 |
| Sunday, January 1, 2017 | 144687000 | 166707000 |
| Monday, January 1, 2018 | 243621000 | 401843000 |
| Tuesday, January 1, 2019 | 331450000 | 560909000 |
| Wednesday, January 1, 2020 | 326860000 | 722343000 |
| Friday, January 1, 2021 | 601033000 | 771182000 |
| Saturday, January 1, 2022 | 477419000 | 877090000 |
| Sunday, January 1, 2023 | 427720000 | 877387000 |
| Monday, January 1, 2024 | 341433000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Blueprint Medicines Corporation have demonstrated significant investments in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Sarepta Therapeutics consistently outpaced Blueprint Medicines in R&D expenditure, with a peak in 2023 where their spending was nearly double that of Blueprint Medicines. Sarepta's R&D expenses grew by approximately 830% from 2014 to 2023, highlighting their aggressive pursuit of new therapies. Meanwhile, Blueprint Medicines also showed a robust increase of around 1,240% in the same period, underscoring their commitment to innovation despite being a smaller player.
This data underscores the dynamic nature of the biotech industry, where strategic investments in R&D can lead to groundbreaking advancements and competitive advantages.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.